Contents
Key Highlights
- ARK Invest purchased 39,691 Tesla shares totaling $14.3M spread across three exchange-traded funds on April 6, 2026
- Tesla’s stock price declined more than 2% to close at $352.82 following disappointing first-quarter delivery figures
- ARK offloaded 25,240 Teradyne shares valued at $7.8M, marking the third consecutive divestment
- Wedbush’s Dan Ives maintained his Buy recommendation with a $600 target price for Tesla
- JPMorgan analyst Ryan Brinkman retained his Sell stance with a $145 valuation
On Monday, April 6, 2026, Cathie Wood’s ARK Invest executed notable portfolio adjustments, accumulating Tesla stock while simultaneously reducing exposure to Teradyne, a semiconductor testing equipment manufacturer.
Tesla’s equity experienced a decline exceeding 2% during Monday’s trading session, settling at $352.82. The downturn followed the electric vehicle manufacturer’s release of first-quarter delivery figures that fell short of market expectations.
Wood’s investment firm acquired 39,691 Tesla shares distributed among three exchange-traded funds: ARK Innovation, ARK Autonomous Technology & Robotics, and ARK Space Exploration & Innovation. The combined transaction value reached approximately $14.3 million.
This acquisition represents part of a broader strategy. ARK has been systematically expanding its Tesla holdings, capitalizing on recent share price depreciation as an entry opportunity.
Concurrently, ARK divested 25,240 Teradyne shares worth $7.8 million from its ARKK and ARKQ portfolios. This marks the continuation of previous sales executed on March 30 and March 31, indicating a strategic withdrawal from the semiconductor testing company.
Analyst Community Remains Divided on Tesla’s Outlook
Wood’s bullish stance on Tesla doesn’t reflect universal sentiment among market analysts.
Dan Ives from Wedbush, recognized as a five-star analyst, reaffirmed his Buy recommendation alongside a $600 price objective following the delivery announcement. While acknowledging the underwhelming results, Ives noted that subdued demand had already been factored into most analysts’ expectations.
Conversely, JPMorgan’s Ryan Brinkman maintained his Sell rating accompanied by a $145 price target, characterizing Tesla’s performance metrics as having “collapsed” across critical categories.
The substantial divergence between these valuations — $145 compared to $600 — underscores the polarized opinions surrounding Tesla’s future trajectory among Wall Street professionals.
Analysis of 32 analysts surveyed within the past three months reveals a consensus Hold rating for Tesla. The breakdown includes 13 Buy ratings, 11 Hold recommendations, and 8 Sell ratings.
The mean price target stands at $393.97, suggesting potential upside of approximately 11.66% from Monday’s closing price.
Additional ARK Portfolio Adjustments on April 6
Beyond the Tesla and Teradyne transactions, ARK sold 29,773 BWX Technologies shares for $6.4 million and divested 8,484 Cameco shares worth $955,043.
The investment firm also liquidated 92,758 Strata Critical Medical shares, generating approximately $384,945. This divestment pattern has persisted since the previous week.
On the acquisition front, ARK purchased 4,394 Kodiak AI shares through its ARKQ ETF, valued at $32,603. The firm has been building its Kodiak AI position since March 30.
Current Market Position
Tesla shares concluded trading on April 6 at $352.82, with the analyst consensus price target of $393.97 indicating modest upside potential from present valuation levels.
